Ventyx Biosciences (VTYX) Fundamental Analysis: Revenue, Earnings & Valuation

1.01 / 10

Underperform

The company exhibits challenging fundamental metrics (1.0/10). Strengths observed in Interest coverage ratio (EBIT / Interest expense) (%) and Total operating revenue (YoY growth rate %), balanced by issues in Accounts receivable turnover ratio and Days sales outstanding. Lead to prudent appraisal.

Analysis Checks(3/10)

Total operating revenue (YoY growth rate %)

Value78.31

Score2/3

Weight2.53%

1M Return0.16%

Days sales outstanding

Value72.62

Score1/3

Weight-22.86%

1M Return-1.52%

Inventory turnover ratio

Value47.79

Score1/3

Weight-19.72%

1M Return-1.31%

Accounts receivable turnover ratio

Value25.75

Score1/3

Weight-14.96%

1M Return-0.98%

PB-ROE

Value-0.02

Score1/3

Weight117.95%

1M Return6.62%

Income tax / Total profit (%)

Value-5.62

Score0/3

Weight-28.91%

1M Return-1.94%

Interest coverage ratio (EBIT / Interest expense) (%)

Value15.65

Score2/3

Weight-12.80%

1M Return-0.83%

Operating revenue (YoY growth rate %)

Value92.51

Score2/3

Weight4.09%

1M Return0.25%

Cost of sales ratio (%)

Value70.39

Score1/3

Weight-22.70%

1M Return-1.52%

Asset-MV

Value-0.49

Score0/3

Weight97.39%

1M Return5.27%

Is VTYX fundamentally strong?

VTYX scores 1.01/10 on fundamentals and holds a Premium valuation at present. Backed by its -34.69% ROE, 0.00% net margin, 0.00 P/E ratio, 0.00 P/B ratio, and 36.60% earnings growth, these metrics solidify its Underperform investment rating.

VTYX(Delisted)

Analysis Checks(3/10)